₹1,027.15-11.60 (-1.12%)
09:43 AM, 13-Dec-2024₹1,027.90-8.45 (-0.82%)
09:29 AM, 13-Dec-2024BSE : 543322
NSE : GLS
Sector : Health care
ISIN Code : INE03Q201024
Last Updated: 13-Dec-2024 | 09:43 AM IST
Market Cap (₹ Cr) | 12,588 |
Traded Value (₹ Cr) | 0.11 |
Volume (Shares) | 1,102 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,335.00 |
52-Week High Date | 16-Sep-2024 |
52-Week Low (₹) | 627.25 |
52-Week Low Date | 21-Dec-2023 |
All Time High (₹) | 1,335.00 |
All Time High Date | 16-Sep-2024 |
All Time Low (₹) | 369.00 |
All Time Low Date | 22-Feb-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 12,597 |
EPS - TTM (₹) [C] | 28.69 |
P/E Ratio (X) [C] | 35.83 |
Face Value (₹) | 2 |
Latest Dividend (%) | 1,125.00 |
Latest Dividend Date | 17-Oct-2023 |
Dividend Yield (%) | 4.82 |
Book Value Share (₹) [C] | 147.95 |
P/B Ratio (₹) [C] | 6.95 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Quant Flexi Cap Fund - Direct (IDCW) | 117.98 | 10,88,244 | 1.61 |
Quant Flexi Cap Fund - Direct (G) | 117.98 | 10,88,244 | 1.61 |
Quant Flexi Cap Fund (G) | 117.98 | 10,88,244 | 1.61 |
Quant Flexi Cap Fund (IDCW) | 117.98 | 10,88,244 | 1.61 |
Quant Business Cycle Fund - Direct (IDCW) | 53.93 | 4,97,480 | 3.51 |
Quant Business Cycle Fund - Direct (G) | 53.93 | 4,97,480 | 3.51 |
Quant Business Cycle Fund - Regular (G) | 53.93 | 4,97,480 | 3.51 |
Quant Business Cycle Fund - Regular (IDCW) | 53.93 | 4,97,480 | 3.51 |
ICICI Pru P.H.D Fund - Direct (G) | 52.48 | 4,84,063 | 1.04 |
ICICI Pru P.H.D Fund - Direct (IDCW) | 52.48 | 4,84,063 | 1.04 |
Load more
Today's Low/High (₹) | 1,025.00 1,039.45 |
Week Low/High (₹) | 1,012.00 1,085.00 |
Month Low/High (₹) | 1,012.00 1,130.00 |
Year Low/High (₹) | 627.15 1,335.00 |
All time Low/High (₹) | 369.00 1,335.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -2.55% | -2.71% | -1.14 | -1.05% |
1 Month | -3.09% | -3.01% | 3.97 | 3.65% |
3 Month | -20.43% | -20.49% | -2.55 | -3.70% |
6 Month | 19.48% | 19.79% | 5.16 | 4.36% |
1 Year | 61.32% | 61.34% | 16.08 | 16.69% |
3 Year | 66.49% | 66.62% | 38.59 | 40.60% |
Managing Director & CEO : Yasir Yusufali Rawjee
Executive Director : Vinod Naik
Independent Non Exe. Director : Manju Agarwal
Independent Non Exe. Director : Taruvai Laxminarayanan Easwar
Chairman (Non-Executive) : HIREN KARSANBHAI PATEL
Independent Director : KAUSHIKBHAI NANDUBHAI PATEL
Independent Director : VIJAYKUMAR RATILAL SHAH
Independent Director : Savan Godialwala
Company Sec. & Compli. Officer : Rudalf Corriea
Registered Office: Plot No. 170-172 Chandramouli, Industrial Est.Mohol Bazarpeth,Solapur,Maharashtra-413213 Ph: 91-2189-234456/234246
1. What's the Glenmark Life Sciences Ltd share price today?
Glenmark Life Sciences Ltd share price was Rs 1,027.15 at 09:43 AM IST on 13th Dec 2024. Glenmark Life Sciences Ltd share price was down by 1.12% from the previous closing price of Rs 1,038.75. Glenmark Life Sciences Ltd share price trend:
2. How can I quickly analyse the performance of the Glenmark Life Sciences Ltd stock?
The performance of the Glenmark Life Sciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Glenmark Life Sciences Ltd?
Glenmark Life Sciences Ltd has a market capitalisation of Rs 12,588 crore.
4. What is Glenmark Life Sciences Ltd's 52-week high/low share price?
The Glenmark Life Sciences Ltd’s 52-week high share price is Rs 1,335.00 and 52-week low share price is Rs 627.25.
5. Is the Glenmark Life Sciences Ltd profitable?
On a consolidated basis, Glenmark Life Sciences Ltd reported a profit of Rs 95.32 crore on a total income of Rs 515.41 crore for the quarter ended 2024. For the year ended Sep 2024, Glenmark Life Sciences Ltd had posted a profit of Rs 95.32 crore on a total income of Rs 515.41 crore.
6. Which are Glenmark Life Sciences Ltd’s peers in the Health care sector?
Glenmark Life Sciences Ltd’s top 5 peers in the Health care sector are Granules India, Sanofi India, Marksans Pharma, Glenmark Life, Sanofi Consumer, P & G Health Ltd, Akums Drugs.
7. Who owns how much in Glenmark Life Sciences Ltd?
Key changes to the Glenmark Life Sciences Ltd shareholding are as follows: